Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Parkinson's Disease

Free Subscription 04.11.2019 1 BMC Neurol 1 J Neural Transm (Vienna) 4 Mov Disord 1 Nervenarzt 1 Neurobiol Dis 2 Neurosci Lett 1 Rev Neurol (Paris)

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

BMC Neurol

1. ILLES A, Balicza P, Molnar V, Bencsik R, et al
   Dynamic interaction of genetic risk factors and cocaine abuse in the background of Parkinsonism - a case report.
   BMC Neurol. 2019;19:260.
   PubMed     Text format     Abstract available
   
   

   
   J Neural Transm (Vienna)

2. SANTOS-GARCIA D, de Deus Fonticoba T, Suarez Castro E, Aneiros Diaz A, et al
   High ultrasensitive serum C-reactive protein may be related to freezing of gait in Parkinson's disease patients.
   J Neural Transm (Vienna). 2019 Oct 31. pii: 10.1007/s00702-019-02096.
   PubMed     Text format     Abstract available
   
   

   
   Mov Disord

3. NOYCE AJ, Bandres-Ciga S, Kim J, Heilbron K, et al
   The Parkinson's Disease Mendelian Randomization Research Portal.
   Mov Disord. 2019 Oct 28. doi: 10.1002/mds.27873.
   PubMed     Text format     Abstract available
   
   
4. BANDRES-CIGA S, Ahmed S, Sabir MS, Blauwendraat C, et al
   The Genetic Architecture of Parkinson Disease in Spain: Characterizing Population-Specific Risk, Differential Haplotype Structures, and Providing Etiologic Insight.
   Mov Disord. 2019 Oct 29. doi: 10.1002/mds.27864.
   PubMed     Text format     Abstract available
   
   
5. LERCHE S, Wurster I, Roeben B, Zimmermann M, et al
   Parkinson's Disease: Glucocerebrosidase 1 Mutation Severity Is Associated with CSF Alpha-Synuclein Profiles.
   Mov Disord. 2019 Oct 30. doi: 10.1002/mds.27884.
   PubMed     Text format     Abstract available
   
   
6. GILAT M, Coeytaux Jackson A, Marshall NS, Hammond D, et al
   Melatonin for Rapid Eye Movement Sleep Behavior Disorder in Parkinson's Disease: A Randomised Controlled Trial.
   Mov Disord. 2019 Oct 31. doi: 10.1002/mds.27886.
   PubMed     Text format     Abstract available
   
   

   
   Nervenarzt

7. KLEINHOLDERMANN U, Melsbach J, Pedrosa DJ
   [Remote assessment of idiopathic Parkinson's disease : Developments in diagnostics, monitoring and treatment].
   Nervenarzt. 2019 Oct 25. pii: 10.1007/s00115-019-00818.
   PubMed     Text format     Abstract available
   
   

   
   Neurobiol Dis

8. AFLAKI E, Stubblefield BK, McGlinchey RP, McMahon B, et al
   A characterization of Gaucher iPS-derived astrocytes: Potential implications for Parkinson's disease.
   Neurobiol Dis. 2019 Oct 26:104647. doi: 10.1016/j.nbd.2019.104647.
   PubMed     Text format     Abstract available
   
   

   
   Neurosci Lett

9. ZHANG Y, Chen J, Xu C, Feng J, et al
   Effects of glucocerebrosidase gene polymorphisms and mutations on the risk of Parkinson's disease dementia: a meta-analysis.
   Neurosci Lett. 2019 Oct 28:134544. doi: 10.1016/j.neulet.2019.134544.
   PubMed     Text format     Abstract available
   
   
10. IWAOKA K, Otsuka C, Maeda T, Yamahara K, et al
    Impaired metabolism of kynurenine and its metabolites in CSF of Parkinson's disease.
    Neurosci Lett. 2019 Oct 22:134576. doi: 10.1016/j.neulet.2019.134576.
    PubMed     Text format     Abstract available
    
    

    
    Rev Neurol (Paris)

11. BLAISE AS, Baille G, Carriere N, Devos D, et al
    Safety and effectiveness of levodopa-carbidopa intestinal gel for advanced Parkinson's disease: A large single-center study.
    Rev Neurol (Paris). 2019 Oct 23. pii: S0035-3787(19)30655.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: